These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36497038)

  • 1. Evidences for Mutant Huntingtin Inducing Musculoskeletal and Brain Growth Impairments via Disturbing Testosterone Biosynthesis in Male Huntington Disease Animals.
    Yu-Taeger L; Novati A; Weber JJ; Singer-Mikosch E; Pabst AS; Cheng F; Saft C; Koenig J; Ellrichmann G; Heikkinen T; Pouladi MA; Riess O; Nguyen HP
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual behavior and testis morphology in the BACHD rat model.
    Novati A; Yu-Taeger L; Gonzalez Menendez I; Quintanilla Martinez L; Nguyen HP
    PLoS One; 2018; 13(6):e0198338. PubMed ID: 29883458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease.
    Soylu-Kucharz R; Baldo B; Petersén Å
    Sci Rep; 2016 Jun; 6():28322. PubMed ID: 27334347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
    Dufour BD; McBride JL
    Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6/1 HD mice.
    Ransome MI; Hannan AJ
    Mol Cell Neurosci; 2013 May; 54():93-107. PubMed ID: 23384443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels.
    Yu-Taeger L; Bonin M; Stricker-Shaver J; Riess O; Nguyen HHP
    Neuropharmacology; 2017 May; 117():260-272. PubMed ID: 28153533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BACHD rats expressing full-length mutant huntingtin exhibit differences in social behavior compared to wild-type littermates.
    Manfré G; Novati A; Faccini I; Rossetti AC; Bosch K; Molteni R; Riva MA; Van der Harst JE; Nguyen HP; Homberg JR
    PLoS One; 2018; 13(2):e0192289. PubMed ID: 29415038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compromised IGF signaling causes caspase-6 activation in Huntington disease.
    Skotte NH; Pouladi MA; Ehrnhoefer DE; Huynh K; Qiu X; Nielsen SMB; Nielsen TT; Nørremølle A; Hayden MR
    Exp Neurol; 2020 Oct; 332():113396. PubMed ID: 32622701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.
    Naia L; Ribeiro M; Rodrigues J; Duarte AI; Lopes C; Rosenstock TR; Hayden MR; Rego AC
    Neuropeptides; 2016 Aug; 58():73-81. PubMed ID: 26876526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
    Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
    J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression.
    Pouladi MA; Xie Y; Skotte NH; Ehrnhoefer DE; Graham RK; Kim JE; Bissada N; Yang XW; Paganetti P; Friedlander RM; Leavitt BR; Hayden MR
    Hum Mol Genet; 2010 Apr; 19(8):1528-38. PubMed ID: 20097678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficits in spermatogenesis but not neurogenesis are alleviated by chronic testosterone therapy in R6/1 Huntington's disease mice.
    Hannan AJ; Ransome MI
    J Neuroendocrinol; 2012 Feb; 24(2):341-56. PubMed ID: 21988129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered reactivity of central amygdala to GABA
    Lamirault C; Yu-Taeger L; Doyère V; Riess O; Nguyen HP; El Massioui N
    Neuropharmacology; 2017 Sep; 123():136-147. PubMed ID: 28587900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease.
    Yu-Taeger L; Petrasch-Parwez E; Osmand AP; Redensek A; Metzger S; Clemens LE; Park L; Howland D; Calaminus C; Gu X; Pichler B; Yang XW; Riess O; Nguyen HP
    J Neurosci; 2012 Oct; 32(44):15426-38. PubMed ID: 23115180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.
    Hult Lundh S; Nilsson N; Soylu R; Kirik D; Petersén Å
    Hum Mol Genet; 2013 Sep; 22(17):3485-97. PubMed ID: 23697793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease.
    Baldo B; Cheong RY; Petersén Å
    PLoS One; 2014; 9(10):e107691. PubMed ID: 25271967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory bulb atrophy and caspase activation observed in the BACHD rat models of Huntington disease.
    Lessard-Beaudoin M; Yu-Taeger L; Laroche M; Singer E; Riess O; Nguyen HHP; Graham RK
    Neurobiol Dis; 2019 May; 125():219-231. PubMed ID: 30738141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
    Duarte AI; Petit GH; Ranganathan S; Li JY; Oliveira CR; Brundin P; Björkqvist M; Rego AC
    Exp Neurol; 2011 Oct; 231(2):314-9. PubMed ID: 21763311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.